Jake Headshot
CEO

Jake Reder, PhD

Michael F Headshot
Chairman Emeritus

Michael W. Fanger, PhD

Joana Headshot
Senior Director of R&D

Joana Murad Mabaera, PhD

Karen Headshot
Director of Operations

Karen Hermanson

Irena Headshot
Director and Boston Site Head

Irena Ivanovska, PhD

Stats 4 3

Adam S Headshot
Scientist

Adam Schmucker, MS

Brady Headshot
Site Head, NYC

Brandy Houser, PhD

Paul Headshot
VP for Research and Discovery

Paul Guyre, PhD

Colleen Headshot
Principal Scientist

Colleen Cooper, PhD

Jean Loup 2
Senior Advisor

Jean-Loup Romet Lemonne, MD

Stats 2 3

Julie Headshot 5
Project Lead

Julie Coleman, PhD

Jin 1
Associate

Jing Gong, PhD

Zachary Headshot 1
Scientist

Zachary Parker, PhD

Charlotte Headshot
Research Technician

Charlotte McCleery

Emily Headshots 2
Scientist

Emily Weyburne, PhD

Andre Headshot 1
Administrative Assistant

André Santos

Stats 1 3

Katherine Headshots 1
Scientist

Katherine Sessions, MS

Stats 5 1

Sarah Headshots 1
Scientist

Sarah McDonald, PhD

Viktor Headshots 1
Scientist

Viktor Martyanov, PhD

Roland Headshot 1
Organizational Consultant

Roland Silverio

Jake Headshot

CEO

Jake Reder, PhD

Jake cofounded Celdara Medical with Prof. Michael Fanger as a way to bridge academic innovation and the marketplace, and currently serves as Director and CEO. Jake guided CM from a concept to the fastest growing company (across all sectors) in the state three years in a row, and is now applying these learnings to the Pandemic Security Initiative. He serves on the Boards of the New Hampshire Academy of Science, Virtici, and MBV, and is Chairman of CairnSurgical, and Javelin Oncology. Jake has lived, studied and worked in Canada, Germany, and the USA, with experiences in research, venture investing, corporate alliances and internal startups, academia, and startups. In 2017 Jake was selected by the US SBA as NH Small Business Person of the Year. Jake earned a B.Sc. with First Class Honors from the University of Waterloo, and a PhD in Chemistry as a Brown-Wetherill Fellow at Purdue University and Ludwig Maximilians Universität. Jake enjoys skiing, hiking, and sailing with his children.

Michael F Headshot

Chairman Emeritus

Michael W. Fanger, PhD

Mike cofounded Celdara Medical with Dr. Jake Reder in 2008. Previously, he was a Founder and Director of Medarex (acquired by BMS in 2009 for $2.4B). While at Medarex, Mike, with Drs. Nils Lonberg and Tibor Keler, selected ipilimumab (Yervoy, formerly MDX-010) for further development. Yervoy is the first therapy to prolong survival for patients with advanced melanoma, and in 2013 was highlighted as Science Magazine’s “Breakthrough of the Year”. He was also instrumental in the development of nivolumab (Opdivo, MDX-1106), the first anti-PD-1 to be approved, as well as bezlotoxumab (Zinplava, MDX-1388) for the treatment of C. difficile, and the third Medarex-originated drug to be approved. Mike was also the founding President and Chief Executive Officer of Celldex Therapeutics Inc. (NASDAQ: CLDX), is a Professor of Microbiology and Immunology and of Medicine at Dartmouth Medical School, and was Chairman of the Department of Microbiology and Immunology from 1992 until 2002. He is a graduate of Wabash College and received his PhD in Biochemistry from Yale University. Mike has authored over 160 publications and over 90 patents and patent applications.

Joana Headshot

Senior Director of R&D

Joana Murad Mabaera, PhD

Joana is a Senior Director of R&D at Celdara Medical where she acts as the operational lead of the company’s R&D effort in addition to developing and managing multiple projects. Joana has over 10 years of research and managerial experience in multiple scientific fields at Celdara, primarily in the area of chimeric antigen receptor (CAR)-based cell therapies for oncology and auto-immune diseases. Prior to Celdara, she was a research scientist at Norris Cotton Cancer Center where she led multiple projects in the field of metabolic disorders. Joana received her PhD in Biochemistry from the University of Sao Paulo in Brazil. She enjoys reading, running and getting together with friends.

Karen Headshot

Director of Operations

Karen Hermanson

Karen is the Director of Operations and has been with Celdara Medical since 2012. With over 15 years of general management experience, she currently oversees the financial, human resources and administrative systems at Celdara. Previous roles include General Manager at Northern Stage in White River Junction, VT and Operations Manager at the Peterborough Players in Peterborough, NH. She has a BA in English and Theater from Middlebury College.

Irena Headshot

Director and Boston Site Head

Irena Ivanovska, PhD

Irena Ivanovska, Ph.D. is a Director and Boston Site Head at Celdara Medical. Irena is responsible for establishing and maintaining Celdara’s extensive network among the Boston/Cambridge academic and entrepreneurial institutions. She is also the Program Lead for several therapeutic development programs in infectious and rare diseases. Prior to Celdara, Irena was a Principal Investigator at Merck and Co., in Respiratory and Immunology and in Oncology at Rosetta Inpharmatics, LLC (a wholly owned subsidiary of Merck and Co.). Irena received a Ph.D. in Molecular Biology from Princeton University, and was a postdoctoral fellow at the Whitehead Institute of MIT. Irena enjoys urban and nature adventures with her daughter.

Stats 4 3
Adam S Headshot

Scientist

Adam Schmucker, MS

Adam is a scientist at Celdara Medical, and has been with the company since 2013. Adam supports multiple programs with his background in general molecular and cellular biology, including regulated work in support of clinical trials. His past experience includes employment as a Scientific Associate at Novartis Institutes for BioMedical Research (NIBR) in Cambridge MA, and as a Research Assistant at Harvard Institutes of Medicine in Boston. He received his BS in biology from UMass Boston, and his MS in molecular and cellular biology from Dartmouth College, studying the transcriptional regulation of matrix metalloproteinases in the lab of Dr. Constance Brinckerhoff. Adam lives on a small farm in northern Vermont, and enjoys alpine ski racing, in particular competing in the United States Ski Association’s New England Masters league.

Brady Headshot

Site Head, NYC

Brandy Houser, PhD

Dr. Brandy Houser is the Site Head for NYC and has led the expansion of Celdara Medical into the Greater NYC region where she is responsible for sourcing and vetting new pipeline assets and all operations. She has led financing, preclinical development, and strategy across the entire NYC pipeline and continues to be a passionate member of the NYC biotech ecosystem through educational content creation as well as through her work as a co-founder of Fiddlehead Foundation, a not-for-profit organization that builds dynamic life science ecosystems. Dr. Houser continues to provide development and intellectual property strategy and know-how to multiple NYC academic institutions and previously supported the NY Economic Development Corporation as the Investment Director of Accelerate New York (Fund II) in their deployment of seed financing to NYC start-up companies. Previously, Brandy was an Investment Associate at Brandon Capital Partners, an Australian venture capital firm and the Alliance Manager for Partners Healthcare, the corporate entity that oversees operations for the Massachusetts General Hospital and the Brigham and Women’s Hospital. During this time, she managed technologies from both hospitals as well as programs for Pfizer’s Center for Therapeutic Innovation. She also helped to create the business and operations plan for The Human Translational Immunology Center at the Brigham and Women’s Hospital. Brandy received her Ph.D. in immunology from Harvard University under the guidance of Dr. Jack Strominger. During her graduate career she was also a commercialization fellow at Harvard Medical School. Dr. Houser is a co-founder and current board member at Women Accelerators, a not-for-profit organization that is geared towards providing the skills women need to advance their careers at all stages.

Paul Headshot

VP for Research and Discovery

Paul Guyre, PhD

Paul is VP for Research and Discovery and is currently Principal Investigator for R&D programs to develop antibacterial, antiviral and immune enhancing small molecules and antibodies. He is also an Active Emeritus Professor of Microbiology and Immunology in the Geisel School of Medicine at Dartmouth. Prior to Celdara, Paul was co-founder of Medarex, the company that produced many FDA approved antibodies including the cancer checkpoint antibodies ipilimumab and nivolumab. Paul received his BA in Biology from Montclair State College and his MS and PhD degrees in Microbiology at the University of New Hampshire. In addition to kayaking, hiking, and cross-country skiing, he enjoys working with the great team at Celdara Medical.

Colleen Headshot

Principal Scientist

Colleen Cooper, PhD

Colleen has been a member of the Celdara Medical team for over four years where she has led or participated in R&D programs ranging from fibrosis, CAR-T development, and infectious disease. Colleen is trained in immunology with specific interests in autoimmunity and infectious disease. She enjoys hiking, skiing, and chasing her chickens and children around the yard.

Jean Loup 2

Senior Advisor

Jean-Loup Romet Lemonne, MD

Dr. Jean-Loup Romet-Lemonne joined Celdara Medical in 2017 as Senior Advisor, working directly with the NYC Site Head advising on all areas of strategy and business development the NYC pipeline. Prior to joining Celdara, he was Senior Advisor of Global Development at Institut Pasteur working directly with the Institut Pasteur’s President for the development of strategic initiatives in the US. Dr. Romet-Lemonne has an extensive biotech career spanning more than three decades and include being the Founder and CEO of IDM Pharma Inc. (NASDAQ:IDMI) now part of Takeda oncology. At IDM, Jean-Loup pioneered anti-cancer immunotherapy with the development of a cellular therapy armed with bi-specific antibodies and brought to market a novel biopharma product that changed patient outcomes in pediatric osteosarcoma. Jean-Loup has been a Senior Scientist in the Cancer Biology Department at the Harvard School of Public Health, and Associate Professor at the Medical School of Tours University in France. Dr. Romet-Lemonne received his MD from Tours University, completed business training at HEC in France, and executive training at Stanford University’s Graduate School of Business. Jean-Loup is an entrepreneur guru and continues to mentor scientific founders. He is also an active contributor to the development of the NYC life-science ecosystem as a co-founder of the Fiddlehead Foundation. Jean-Loup enjoys running all over NYC, but most especially in Central Park and along the Hudson River.

Stats 2 3
Julie Headshot 5

Project Lead

Julie Coleman, PhD

Julie is a project leader at Celdara Medical where she currently leads the DRIVEN Accelerator Hub and two R&D programs in antimicrobial resistance and autoimmune disease, respectively. Prior to Celdara, Julie was a consultant at Putnam Associates where she provided scientific and analytical insights to clients in the biotech and pharmaceutical industry. Julie consulted in therapeutic areas spanning gene therapy, molecular therapies, cell therapy, diagnostics, vaccines, and biosimilars; diseases included breast cancer, hematological malignancies, neurological disorders, infertility disorders, and meningitis. Julie received her BA in Biology and English from Bowdoin College and her PhD in Neuroscience from Tufts University. She enjoys reading, hiking, and cross-country skiing, but most of all, she loves dancing with friends!

Jin 1

Associate

Jing Gong, PhD

Jing is an Associate at Celdara Medical NYC. She supports the entire New York pipeline, spanning RNA platforms to antibody therapies to diagnostics. Prior to Celdara, Jing was a project manager at the Translational Research Accelerator, hosted at Columbia University, where she worked with a cross-functional team of MDs, scientific founders, researchers and executives-in-residence to reach IND-enabling milestones. Jing also has worked extensively with Columbia Technology Ventures, aiding Columbia University researchers in the technology development process. Jing received her BS in Chemical Engineering from UCLA and her MS/PhD in Biomedical Engineering from Columbia University. She enjoys rock climbing, backpacking and trying to complete the recipes in her Milk Street subscription.

Zachary Headshot 1

Scientist

Zachary Parker, PhD

Zach is a Scientist at Celdara Medical where he currently drives the hands-on science for programs on autoimmune disease. Before Celdara, Zach was a postdoc at the University of Chicago where he studied the innate immune response to RNA viruses, work that has become particularly relevant during the SARS-CoV-2 pandemic. Zach has research experience in labs working on DNA viruses in vivo, as well as studying the bacterium Vibrio Cholerae, giving him a breadth of microbiology experience. Zach received his BS and MS in Biology from Appalachian State University and his PhD in Microbiology and Immunology from Dartmouth College. He enjoys cycling, hiking, cross country skiing, brewing, and spending time with his two cattle dogs.

Charlotte Headshot

Research Technician

Charlotte McCleery

Charlotte is a lab technician at Celdara Medical. Her responsibilities include machine maintenance, daily tasks to keep the lab running smoothly, ordering, and putting out any fires that come her way. Charlotte is also directly involved in the lab operations of Celdara’s diagnostic service. After graduating from Keene State College, Charlotte’s passion for science allowed her to explore the world of marine biology which brought her to several islands to conduct underwater research. Following these experiences, she was a research assistant in a breast cancer research lab at Dartmouth College for two years prior to joining Celdara. She enjoys her dogs, the great outdoors, and the oceans.

Emily Headshots 2

Scientist

Emily Weyburne, PhD

Emily is a Scientist at Celdara Medical. Prior to Celdara, Emily was a postdoc at Dartmouth College where she used human cell lines to research the effects of mutations in a protein complex necessary for cell division. She was also President of the Dartmouth College Postdoc Association (DCPDA) for two years. Emily received her BA in Biochemistry from Colgate University and her PhD in Molecular Cancer Biology from Dartmouth College. She enjoys rock climbing, yoga, and cooking.

Andre Headshot 1

Administrative Assistant

André Santos

André is an Administrative Assistant at Celdara Medical where he currently supports the DRIVEN Accelerator Hub and Celdara’s day to day operations. Prior to Celdara, André was a clinician at West Central Behavioral Health where he worked one on one with community members suffering from mental illness. André also was an active contributor to the Grafton County Mental Health Court, an alternative sentencing program where the mission is to reduce recidivism and provide treatment options for individuals with mental illness within the criminal justice system. André received his BS in Psychology and Business Administration from Plymouth State University. He enjoys campfires, cast-iron cooking, and making noises with a guitar.

Stats 1 3
Katherine Headshots 1

Scientist

Katherine Sessions, MS

Katherine Sessions is a Scientist at Celdara Medical where she works to validate and optimize potential new therapeutics. She has had a diverse career, working in the medical research, adaptive physiology and fisheries science fields. Her guiding principle throughout has been to add knowledge and hopefully a little good to the world. Prior to Celdara, she was a Research Associate for the United States Department of Veterans Affairs. There, she worked on advancing CRISPR-Cas9 as a genetic editing tool for the treatment of HIV. She received her BS in biology from Rochester Institute of Technology and her MS in biology, from the University of Regina. She enjoys hiking, running, camping and all things outdoors. But most of all, she loves doing these things with her dog, Lily.

Stats 5 1
Sarah Headshots 1

Scientist

Sarah McDonald, PhD

Sarah is a Scientist at Celdara Medical. She joined in March 2020 and is working in protein production and purification. Prior to joining Celdara, she worked as a protein production scientist and lab manager at Avitide Inc. and before that at the Thayer School of Engineering at Dartmouth. She has completed postdocs at SRI International and at the Monterey Bay Aquarium Research Institute. Sarah received a BSc in Marine Biology from the University of Liverpool, a MSc in Biodiversity from Imperial College London and a PhD in Marine Microbiology from the Stazione Zoologica in Italy in collaboration with the Open University in the UK. She enjoys horse riding, gardening, knitting and reading.

Viktor Headshots 1

Scientist

Viktor Martyanov, PhD

Viktor is a Bioinformaticist at Celdara Medical where he is working with academia and industry partners to analyze clinical trials using genomic data and bring Celdara’s pipeline to its full potential. Prior to Celdara, Viktor worked at Geisel School of Medicine at Dartmouth to identify molecular biomarkers of clinical response in systemic sclerosis, a rare and deadly autoimmune disease. Viktor received his BS in Genetic Biology from Purdue University and his PhD in Biological Sciences from Dartmouth College. Viktor enjoys reading Wall Street Journal, exploring community gardens, ordering DoorDash and watching survival shows on Hulu.

Roland Headshot 1

Organizational Consultant

Roland Silverio

Roland is a trusted advisor to the leadership team at Celdara Medical. Prior to Celdara, Roland led Human Resources globally in multiple sectors and has successfully coached CEOs, Presidents, General Managers, and other business leaders. Roland’s several international assignments in China, France, the United Kingdom, Malaysia and Indonesia have given him a unique perspective on leadership in the global market place. Roland is a graduate of Northeastern University and has received both an MS and CAGS in Education from the University of Massachusetts. He enjoys spending time with his children and grandchildren.

Board of Directors

Eric Headshot
Director

Eric Achtmann

Ken Headshots 1
Chairman

Kennett F. Burnes

Michael F Headshot
Chairman Emeritus

Michael W. Fanger, PhD

Paul Headshot
VP for Research and Discovery

Paul Guyre, PhD

Lita Headshot 1
Director

Lita Nelsen

Steven Headshot
Director

Steven Potter

Jake Headshot
CEO

Jake Reder, PhD

Jan Van Headshot
Director

Jan Van de Winkel, PhD

Eric Headshot

Director

Eric Achtmann

Eric is a Managing Director at Global Capital Group, Director at Javelin Oncology, Founding Member of Meggitt plc’s Technology Advisory Board, as well as a Senior Advisor to McKinsey and the European Commission. Eric was previously Managing Partner at PolyTechnos Venture-Partners, a pan-European Life Science and Tech venture fund; Co-founder & Executive Chairman of V-Nova, a world leader in video compression; and Architect of Costa Coffee’s “Project Marlow”, which led to the $5.1b acquisition by Coca-Cola. He holds multiple degrees in engineering and finance, including from MIT and the MIT Sloan School of Management. He is a Professor of Practice at the MIT-founded Skoltech and former Senior Lecturer at the TU Munich and ETH Zurich. Eric enjoys flying and making great food, from German breads to kimchi.

Ken Headshots 1

Chairman

Kennett F. Burnes

Ken is retired Chairman, President, and CEO of Cabot Corporation and was previously a partner at Choate, Hall & Stewart. He was Director of State Street Corporation for 10 years and was a member of the Dana Farber Cancer Institute’s Board of Trustees. Ken is currently Chairman of the Board of the New England Conservatory, Chairman of the Board of Trustees of the Schepens Eye Research Institute, and board member and treasurer of the Epiphany School. Ken holds both an LL.B. and B.A. degree from Harvard University.

Michael F Headshot

Chairman Emeritus

Michael W. Fanger, PhD

Mike cofounded Celdara Medical with Dr. Jake Reder in 2008. Previously, he was a Founder and Director of Medarex (acquired by BMS in 2009 for $2.4B). While at Medarex, Mike, with Drs. Nils Lonberg and Tibor Keler, selected ipilimumab (Yervoy, formerly MDX-010) for further development. Yervoy is the first therapy to prolong survival for patients with advanced melanoma, and in 2013 was highlighted as Science Magazine’s “Breakthrough of the Year”. He was also instrumental in the development of nivolumab (Opdivo, MDX-1106), the first anti-PD-1 to be approved, as well as bezlotoxumab (Zinplava, MDX-1388) for the treatment of C. difficile, and the third Medarex-originated drug to be approved. Mike was also the founding President and Chief Executive Officer of Celldex Therapeutics Inc. (NASDAQ: CLDX), is a Professor of Microbiology and Immunology and of Medicine at Dartmouth Medical School, and was Chairman of the Department of Microbiology and Immunology from 1992 until 2002. He is a graduate of Wabash College and received his PhD in Biochemistry from Yale University. Mike has authored over 160 publications and over 90 patents and patent applications.

Paul Headshot

VP for Research and Discovery

Paul Guyre, PhD

Paul is VP for Research and Discovery and is currently Principal Investigator for R&D programs to develop antibacterial, antiviral and immune enhancing small molecules and antibodies. He is also an Active Emeritus Professor of Microbiology and Immunology in the Geisel School of Medicine at Dartmouth. Prior to Celdara, Paul was co-founder of Medarex, the company that produced many FDA approved antibodies including the cancer checkpoint antibodies ipilimumab and nivolumab. Paul received his BA in Biology from Montclair State College and his MS and PhD degrees in Microbiology at the University of New Hampshire. In addition to kayaking, hiking, and cross-country skiing, he enjoys working with the great team at Celdara Medical.

Lita Headshot 1

Director

Lita Nelsen

Lita is the retired Director of MIT’s Technology Licensing Officer, where she was for 30 years. She is widely published in the field, and has advised a number of international governments on technology transfer policies. She is a founder of PraxisAuril in the UK, and was awarded a Member of the British Empire for her aid to UK universities in technology transfer. Lita is currently a consultant in technology transfer policies and licensing agreements, primarily in the biotechnology sphere, and serves on a number of non-profit boards. She received her B.S. and M.S. in Chemical Engineering from MIT, and an MBA as a Sloan Fellow from the MIT Sloan School of Management.

Steven Headshot

Director

Steven Potter

Steve is currently the Managing Partner of the US business of Odgers Berndtson and Founder and CEO of Allyon Solutions, LLC. He was previously the cofounder, CEO, and Chairman of both Sextant Search Partners and Axiom Consulting; the CEO of TMP Worldwide Executive Search; the CEO of Highland Search Group; and a Managing Director, Head of Global Banking and Merchant Banking, at Russell Reynolds Associates, Inc. Steve has a BA in History and English from Yale University.

Jake Headshot

CEO

Jake Reder, PhD

Jake cofounded Celdara Medical with Prof. Michael Fanger as a way to bridge academic innovation and the marketplace, and currently serves as Director and CEO. Jake guided CM from a concept to the fastest growing company (across all sectors) in the state three years in a row, and is now applying these learnings to the Pandemic Security Initiative. He serves on the Boards of the New Hampshire Academy of Science, Virtici, and MBV, and is Chairman of CairnSurgical, and Javelin Oncology. Jake has lived, studied and worked in Canada, Germany, and the USA, with experiences in research, venture investing, corporate alliances and internal startups, academia, and startups. In 2017 Jake was selected by the US SBA as NH Small Business Person of the Year. Jake earned a B.Sc. with First Class Honors from the University of Waterloo, and a PhD in Chemistry as a Brown-Wetherill Fellow at Purdue University and Ludwig Maximilians Universität. Jake enjoys skiing, hiking, and sailing with his children.

Jan Van Headshot

Director

Jan Van de Winkel, PhD

Jan is President, CEO and CoFounder of Genmab A/S. Genmab is the largest biotech in Europe with three approved partnered products: DARZALEX® (daratumumab), Arzerra® (ofatumumab) and TEPEZZA™ (teprotumumab-trbw). He is also a Professor in Immunotherapy at the University Medical Center Utrecht. Jan was VP and Scientific Director of Medarex Europe and is chairman of the board of directors of Hookipa Pharma Inc. and member of the board of directors of Leo Pharma. He holds M.S. and Ph.D. degrees from the University of Nijmegen.